|
J Biol Chem, Vol. 275, Issue 7, 4871-4879, February 18, 2000
The Molecular Structure of Hyperthermostable Aromatic
Aminotransferase with Novel Substrate Specificity from
Pyrococcus horikoshii*
Ikuo
Matsui §,
Eriko
Matsui ,
Yukihiro
Sakai ,
Hisasi
Kikuchi¶,
Yutaka
Kawarabayasi ¶,
Hideaki
Ura ,
Shin-ichi
Kawaguchi ,
Seiki
Kuramitsu , and
Kazuaki
Harata §
From the National Institute of Bioscience and Human
Technology, Tsukuba, Ibaraki 305, the ¶ National Institute of
Technology and Evaluation, Ministry of International Trade and
Industry, Nishihara, Shibuyaku, Tokyo, and the Department of
Biology, Graduate School of Science, Osaka University, Toyonaka,
Osaka 560-0043, Japan
 |
ABSTRACT |
Aromatic amino acid aminotransferase
(ArATPh), which has a melting temperature of 120 °C, is
one of the most thermostable aminotransferases yet to be discovered.
The crystal structure of this aminotransferase from the
hyperthermophilic archaeon Pyrococcus horikoshii was
determined to a resolution of 2.1 Å. ArATPh has a
homodimer structure in which each subunit is composed of two domains,
in a manner similar to other well characterized aminotransferases. By
the least square fit after superposing on a mesophilic ArAT, the
ArATPh molecule exhibits a large deviation of the main
chain coordinates, three shortened -helices, an elongated loop
connecting two domains, and a long loop transformed from an -helix,
which are all factors that are likely to contribute to its
hyperthermostability. The pyridine ring of the cofactor pyridoxal
5'-phosphate covalently binding to Lys233 is stacked
parallel to F121 on one side and interacts with the geminal
dimethyl-CH/ groups of Val201 on the other side. This
tight stacking against the pyridine ring probably contributes to the
hyperthermostability of ArATPh. Compared with other ArATs,
ArATPh has a novel substrate specificity, the order of
preference being Tyr > Phe > Glu > Trp > His
Met > Leu > Asp > Asn. Its relatively weak
activity against Asp is due to lack of an arginine residue
corresponding to Arg292* (where the asterisk indicates that
this is a residues supplied by the other subunit of the dimer) in pig
cytosolic aspartate aminotransferase. The enzyme recognizes the
aromatic substrate by hydrophobic interaction with aromatic rings
(Phe121 and Tyr59*) and probably recognizes
acidic substrates by a hydrophilic interaction involving a hydrogen
bond network with Thr264*.
 |
INTRODUCTION |
Aminotransferases have been widely applied in the large scale
biosynthesis of unnatural amino acids, which are in increasing demand
by the pharmaceutical industry for peptidomimic and other single-enantiomer drugs (1). These enzymes have been classified into
four families (I-IV) (2). Family I includes the aspartate aminotransferases (AspATs),1
aromatic amino acid aminotransferases (ArATs), alanine ATs, and histidinol phosphate aminotransferase. All members of Family I efficiently utilize -ketoglutarate as an amino donor and glutamate as an amino acceptor. Eleven residues are invariant among the enzymes
belonging to Family I (2). The members of Family I are further
subdivided into three subfamilies according to their amino acid
sequence alignment (2, 3). Subfamily I comprises AspATs isolated
from Escherichia coli, yeast, chicken, pig, and other
organisms, and ArATs from prokaryotes (E. coli and
Paracoccus denitrificans). In this subfamily, an arginine
residue (Arg292*, according to the numbering for pig
cytosolic AspAT (cAspATp) (4))2 is conserved. The
Arg292* residue interacts with the -carboxyl moiety of
the dicarboxylic substrates (5-7). The arginine residue was not found
in all members of subfamily I , despite the normally high degree of
conservation in active site residues (2, 8, 9). Subfamily I is
specialized for histidine biosynthesis (2, 4).
Recently, much research effort has been directed toward the isolation
and characterization of enzymes from hyperthermophilic archaea.
Interest in these enzymes has increased, because of their biotechnological potentials for novel application (10, 11) and because
of the need for a better understanding of their intrinsic resistance to
heat and denaturing processes. The mechanisms of their stability
continue to be challenging and unresolved problems in biochemistry and
biotechnology (10-13). An aspartate aminotransferase gene homolog
(open reading frame identification number 1371) was identified
via genome sequencing in the hyperthermophilic archaeon Pyrococcus horikoshii (14, 15). The gene
(ArATPh) was expressed in E. coli, the product
was purified to homogeneity, and the enzyme ArATPh was
determined to be an aromatic aminotransferase belonging to
subfamily I . We present the first report of the molecular structure
of hyperthermophilic ArAT, which is an essential step in the effort to
comprehend its stabilizing mechanisms. We also discuss its novel
substrate specificity and dual substrate binding mechanism for both
acidic and aromatic amino acids on the basis of its active site structure.
 |
MATERIALS AND METHODS |
Chemicals--
The pET-11a vector and ultracompetent E. coli XL2-Blue MRF' cell were purchased from Stratagene (La Jolla,
CA). The pET-15b vector and E. coli strain BL21 (DE3) were
obtained from Novagen (Madison, WI). Vent DNA polymerase was purchased
from New England Biolabs (Beverly, MA). Restriction enzymes were
purchased from Promega and Toyobo (Osaka, Japan) and were used
according to the manufacturer's recommendations. Ultrapure dNTP
solution was obtained from Amersham Pharmacia Biotech.
L-Cysteinsulfinic acid, bovine DNase I, -NADH, and
malate dehydrogenase from porcine heart (mitochondrial) were purchased
from Sigma. 2-Oxoglutaric acid monosodium salt and DTNB were purchased
from Nacalai Tesque (Kyoto, Japan).
Isopropyl- -D-thiogalactopyranoside was purchased from
Takara Shuzo (Otsu, Shiga, Japan).
Cloning of Genes and Construction of Expression Vector--
The
complete genome sequence of P. horikoshii has been reported
by Kawarabayasi et al. (14, 15). Standard cloning techniques were used throughout. The aromatic aminotransferase (ArATPh)
gene was amplified using polymerase chain reaction with primers having NdeI and BamHI restriction sites according to a
method reported previously (16). The sequences of the primers were
5'-TTTTGTCGACTTACATATGGCGCTAAGTGACAGA-3' (underlining
indicates the upper primer containing the NdeI site) and
5'-TTTTGGTACCTTTGGATCCTTAACCAAGGATTTAAACTAG-3'
(underlining indicates the lower primer containing the
BamHI site). The amplified gene was digested by
NdeI and BamHI, and the digested fragment coding
for ArATPh was inserted in an expression vector pET-11a cut
with the same restriction enzymes. The nucleotide sequence of the
inserted gene was verified by sequencing on an Applied Biosystems 373A
DNA sequencer (Taq DyeDeoxy Terminator Cycle Sequencing Kit,
Perkin-Elmer).
Overexpression and Purification of Recombinant Protein--
The
cloned gene was expressed using the pET-11a vector system in the host
E. coli strain BL21 (DE3) according to the manufacturer's instructions. The host cells were transformed with the constructed pET-11a/ArATPh plasmid, after which the production of the
protein was performed according to the method described previously
(16). The concentration of the expressed protein was determined using a
Coomassie protein assay reagent (Pierce) and utilizing bovine serum
albumin as the standard protein. The crude enzyme solution was prepared
from the transformant E. coli, and the enzyme was purified
using chromatography in a HiTrap Q column (Amersham Pharmacia Biotech)
and a HiLoad Superdex 200 column (Amersham Pharmacia Biotech) (16). The
purity of the enzyme samples was analyzed using SDS-polyacrylamide gel
electrophoresis (17) and isoelectric focusing using a PhastSystem
(Amersham Pharmacia Biotech). Protein sequencing of recombinant
ArATPh was performed by Takara Shuzo Co. Ltd. (Otsu, Shiga,
Japan) using a protein sequencer PSQ-1 (Shimazu, Japan).
Pre-steady-state Kinetic Studies of Half-transamination
Reactions--
Aliphatic amino acid substrates with unbranched side
chains were used to estimate the hydrophobic substrate specificities of
the aminotransferase. We used L-form amino acids for the
sC3-sC6 substrates and DL-isoforms for the sC7-sC9
substrates (18); the aminotransferase tested here cannot use
D-form amino acids as substrates. All measurements were
carried out at pH 8.0 and 25 °C. The buffer solution contained 50 mM HEPES with 100 mM KCl and 10 mM EDTA.
The slow reaction was followed spectrophotometrically by monitoring the
change in absorption of the bound coenzyme at 380 nm. When the
kapp value was directly proportional to the
substrate concentration, the
kmax/Kd value was calculated
from the following equation (18, 19).
|
(Eq. 1)
|
Thus, the catalytic efficiency,
kmax/Kd, was given by
kapp/[S] for these substrates. The rapid
reactions were followed using stopped flow spectrophotometers from
Union Giken (model RA-401) or Applied Photophysics (model SX-17MW). The
reaction curves conformed to a single-exponential process. The free
energy differences ( GT )
between the transition state and unbound enzyme plus substrate for
various substrates were calculated using the following equation (19,
20).
|
(Eq. 2)
|
where R is the gas constant, T is the
absolute temperature, kB is the Boltzmann
constant, and h is the Planck constant.
Temperature Dependence of Activity for Overall Transamination
Reaction--
The overall transamination reaction for the acidic
substrate aspartate was measured spectrophotometrically at 340 nm using a coupled assay with malate dehydrogenase and NADH at pH 8.0 and 25 °C (20, 21), and the steady-state kinetics parameters, Km and kcat, were determined.
The reaction mixtures contained 50 mM HEPES, 100 mM KCl, 0.01 mM EDTA, 0.1 mM NADH,
2.5 units/ml malate dehydrogenase, 1 µM
ArATPh, and various concentrations of
L-aspartate or 2-oxoglutarate. The activity of the
hydrophobic substrate phenylalanine was measured at pH 8.0 and
25 °C. The product formation of the phenylpyruvate was monitored at
280 nm using the molar extinction coefficient difference of 450 cm 1 M 1 between phenylpyruvate
and phenylalanine (22). The reaction mixture contained 50 mM HEPES, 100 mM KCl, 20 nM
ArATPh, and various concentrations of
L-phenylalanine or 2-oxoglutarate.
To determine temperature dependence, the activities for five sets of
substrates, tryptophan-2-ketoglutarate (Trp-2OG),
tryptophan-phenylpyruvate (Trp-KetoPhe), histidine-2-ketoglutarate
(His-2OG), histidine-phenylpyruvate (His-KetoPhe), and
glutamate-phenylpyruvate (Glu-KetoPhe) were measured at different
temperatures (25-90 °C) at pH 8.0. Based on the following molar
extinction coefficients of 2-oxo acid derivatives, the concentration of
the enzymatic products were calculated: at 310 nm, 24.5 and 3200 cm 1 M 1 for 2OG and
3-indolepyruvate, respectively, and at 280 nm, 21 and 450 cm 1 M 1 for 2OG and KetoPhe
(22), respectively. The product from His was monitored at 293 nm using
a coefficient difference of 3050 cm 1
M 1 obtained to subtract the spectrum for the
reaction of histidine with the PLP enzyme from that of the pyridoxamine
5'-phosphate enzyme (23). The reaction mixture contained 50 mM HEPES, 100 mM KCl, 20 nM
ArATPh, and various concentrations of amino acids or
keto-acids.
Optimum Temperature and Thermostability for ArATPh
Reaction--
The optimum temperature for ArATPh activity
was measured as described previously (24). The enzyme reaction was
carried out in a solution (3.05 ml) containing ArATPh (3.8 nM), L-cysteinsulfinic acid (12.8 mM), 2-oxoglutaric acid (2.0 mM), EDTA (98 µM), and DTNB (1.5 mM) in 50 mM
phosphate buffer (pH 6.5) at 30-98 °C, and the rate of increase in
absorbance at 412 nm because of the reduction of DTNB was monitored for
5 min. For controls, the reactions were performed under the same
conditions but without the enzyme.
To determine thermostability, the enzyme solutions (0.1 mg/ml) in 20 mM phosphate buffer (pH 6.5) were incubated at 95 °C for
90 and 120 min and then autoclaved in sealed Eppendorf tubes at
110 °C for 5, 15, 30, and 90 min. The heated enzymes were assayed in
duplicate at 90 °C, as described elsewhere (24).
Spectroscopy of Coenzyme--
To investigate the ionization of
the internal Schiff base, the absorption spectra of the enzyme at a
protein concentration of approximately 20 µM in a 1-cm
cell were measured at 25 °C using a Hitachi spectrophotometer (model
U-3000). The buffer solution was comprised of 100 mM KCl,
0.01 mM EDTA, and a buffer component of 50 mM
MES, 50 mM PIPES, or 50 mM HEPES.
pH Stability--
The gross conformation and pH stability of
ArATPh were studied using CD spectroscopy. The CD spectra of
ArATPh, at a protein concentration of approximately 0.1 mg/ml in a 1-mm cell, were measured at 25 °C using a
spectropolarimeter (J-720W, Jasco, Japan). The solution was comprised
of 100 mM KCl and a buffer component of 50 mM
acetate, 20 mM phosphate, 50 mM borate, or 20 mM carbonate.
Scanning Calorimetry--
The thermal denaturation curve of
ArATPh was measured using a Nano Differential Scanning
Calorimeter (CSC5100, Calorimetry Science Co.). Before measurement, the
enzyme solution (1 mg/ml) was dialyzed against 20 mM
phosphate buffer, pH 6.5, and degassed for 15 min using an aspirator.
The sample cell was filled with the degassed enzyme solution, and the
reference cell was filled with the outer solution from the dialysis.
The measurement was performed at a temperature range of 0-125 °C. A
scan rate of 1 K/min was used throughout. The denaturation profile was
analyzed using Nano differential scanning calorimetry CpCalc data
analysis software (Calorimetry Science Co.).
Structure Determination, Refinement, and Model
Building--
Crystals were obtained using the hanging drop vapor
diffusion technique. An equi-volume of 3 M 1,6-hexane-di-ol
solution at pH 7.5 (100 mM HEPES buffer) containing 10 mM MgCl2 was added to a protein solution
containing 1.6% ArATPh and 20 µM
pyridoxal-5'-phosphate and a 10-µl droplet of the solution was
equilibrated with 1 ml of a 3 M 1,6-hexane-di-ol solution.
Crystals were grown at room temperature for 1 week. X-ray diffraction
experiments were carried out on an Enraf FAST differactometer equipped
with a FR571 generator (40 kV, 50 mA; focal spot size, 0.2 mm), and
intensity data were collected at a resolution of 2.1 Å for the native
crystal and at 3.0 Å for the heavy atom derivatives.
The structure was determined using the multiple isomorphous replacement
method. A structure model was built on an electron density map
calculated with multiple isomorphous replacement phases with a figure
of merit of 0.93. The amino acid sequence was unambiguously traced on
the map and most of the side chains were identified. The structure was
refined to a resolution of 2.1 Å using X-PLOR (25). All coordinates
have been deposited with the RCSB Protein Data Bank as entry 1DJU. In
the substrate-binding model, the coordinates of ArATPh with
water molecules were fixed, but the torsion angles of the substrates
were changed to find the best fitting configuration to the enzyme.
Sequence Alignment and Phylogenetic Tree--
We performed a
sequence alignment of 11 aminotransferases within subfamily 1 using
the GeneWorks program (IntelliGenetics, Inc., Mountain View, CA) based
on a PAM-250 scoring matrix. The compared enzymes were as follows:
ArATPh, AspATs from thermophilic Bacillus sp.
(26), Thermus thermophilus HB8 (8), Rhizobium meliloti (27), Bacillus subtilis (28),
Methanococcus jannaschii (29), and Sulfolobus
solfataricus (30); tyrosine ATs from human (31), rat (32), and
Trypanosoma cruzi (33); and alanine ATs from human (34), rat
(35), and Panicum miliaceum (36). Phylogenetic trees for the
same sequences were constructed using the GeneWorks program based on
the unweighted pair group method with an arithmetic mean (37).
 |
RESULTS |
Sequence Alignment and Phylogenetic Tree of ArATPh--
Because we
were unable to construct a united alignment among aminotransferases
belonging to the subfamilies 1 , 1 , and 1 from P. horikoshii, other archaea, bacteria, and eukaryotes because of a
lack of similarity between each subfamily, we made the alignment using
11 candidates belonging to subfamily 1 to identify its conserved
residues. The best alignment was obtained with the five thermophilic
aminotransferases shown in Fig. 1.
ArATPh showed poor identity to E. coli AspAT
(AspATEc) (38), E. coli ArAT (ArATEc)
(39, 40), and P. denitrificans ArAT (ArATPd)
(41), which are well known members of subfamily I . According to
these results, ArATPh was nominated to the aminotransferase
subfamily I (2, 3). Furthermore, ArATPh was closer to the
thermophilic AspATs than to the tyrosine ATs from eukaryotes in
subfamily I .

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 1.
Aligned amino acid sequences of five
thermophilic aminotransferases belonging to subfamily
I . Thermus, T. thermophilus HB8 (8); Bac.sp, thermophilic
Bacillus sp. YM-2 (26); Metha2, M. jannaschii isozyme 2 (29); Ph, P. horikoshii
(present paper); Sulfo, S. solfataricus (30). The
conserved residues, identified automatically by the GeneWorks program,
are shown in open boxes. Large capital letters
indicate the completely conserved residues among the 11 candidates
listed under "Materials and Methods." The numbering is
according to cAspATp (4). R292 indicates the position
corresponding to Arg292* in cAspATp.
|
|
Overexpression, Purification, and Oligomeric Structure of
Recombinant ArATPh--
The ArATPh gene was abundantly
expressed in E. coli BL21 (DE3), and the recombinant
ArATPh comprised 30% of the total protein. After heat
treatment at 80 °C for 15 min, which removed most of the endogenous
E. coli proteins, the protein was purified to homogeneity by
sequential chromatography on HiTrap Q and HiLoad Superdex 200 columns.
The final preparation of the ArATPh displayed a single band
(42 kDa) on SDS-polyacrylamide gel electrophoresis. Isoelectric focusing indicated a pI value of 5.2 for ArATPh. The
N-terminal sequence of the recombinant ArATPh was
ALSDRLELVSASEIRKL, which was identical to that deduced from the DNA
sequence without the initial methionine residue. The enzyme had an
apparent molecular mass of 56 kDa as estimated by gel filtration on a
calibrated TSK gel G2000SWXL column, and a subunit molecular mass of 42 kDa as estimated by SDS-polyacrylamide gel electrophoresis. This
suggests that it has a dimeric structure similar to other
aminotransferases (24, 34, 42-45).
Optimum Temperature of the Recombinant ArATPh--
The optimum
temperature of this enzyme was 90 °C, which represents an extreme
thermophilic characteristic. The kapp of
ArATPh increased steadily in the range of the temperature
studied here. The kapp for
L-cysteinsulfinic acid and 2-ketoglutaric acid as substrates was 1.39 × 102 s 1 at
90 °C and pH 6.5. Like several other thermophilic enzymes (46-48),
the recombinant ArATPh shows a thermal transition in
conformation as indicated in Arrhenius plots near 70 °C (data not shown).
Substrate
Specificity--
GT ,
the free energy difference between the unbound enzyme plus substrate (E + S) and the transition state (ES ), was calculated for
various substrates using Equation 1 or 2. A smaller
GT value indicates
higher enzyme activity. As shown in Table
I, Tyr is the best substrate having a
kmax/Kd
(M 1 s 1) value of 1.2 × 105. Three aromatic amino acids (Tyr, Phe, and Trp) and Glu
are good substrates for ArATPh, whereas Asp is a poor
substrate having a kmax/Kd
(M 1 s 1) value of 9.1. ArATPh showed moderate activity on His. The activity of
ArATPh toward a series of aliphatic substrates with straight side chains was enhanced as the side chain length increased. The activity of ArATPh was maximal for an 8-carbon substrate
(2-amino octanoic acid).
View this table:
[in this window]
[in a new window]
|
Table I
The kmax/Kd values of ArATPh for the
half-transamination reactions with a series of substrates at pH 8.0 and
25 °C
The chain lengths of the straight substrate are shown in parentheses.
|
|
Comparison of the Substrate Specificity for ArATs from Different
Origins--
The steady-state kinetic parameters of ArATPh
using an overall transamination reaction between 2OG and Asp or between
2OG and Phe were measured at 25 °C (the upper section of Table
II). The enzyme activity against Phe was
high with a kcat/Km value of
5.2 × 103 M 1
s 1, but the activity against Asp was very low (2.2 M 1 s 1). The difference between
these kcat/Km values was on the order of 103, whereas the difference for
ArATEc (from E. coli) and ArATPd (from
P. denitrificans) was approximately 10-fold. At the optimum reaction temperature of 90 °C, ArATPh has approximately a
102- and 10-fold higher activity for His and Glu,
respectively, than does ArATEc or ArATPd at
25 °C (Table II). This indicates that Glu is the best acidic
substrate for ArATPh.
View this table:
[in this window]
[in a new window]
|
Table II
Comparison of the kinetic parameters (kcat/Km
s 1 M 1) of the overall transamination
reactions at pH 8.0 among ArATs from hyperthermophilic and mesophilic
organisms
The reaction temperatures are shown in parentheses.
|
|
Spectroscopic Properties of the Enzyme-bound Coenzymes PLP and
Pyridoxamine 5'-Phosphate--
An internal Schiff base is formed
between Lys233 (corresponding to Lys258 in
cAspATp) and the aldehyde group of the coenzyme PLP. The reaction produces a spectral change in the visible absorption region. Changes in
the apparent molar absorption coefficients for the PLP form enzyme at
420 and 370 nm were plotted against pH. The Schiff base pKa value was determined to be 5.1.
Three-dimensional Structure of ArATPh--
The space group of the
protein crystal is P212121, and the
cell dimensions are a = 64.01, b = 124.87, and c = 128.78 Å. The structure was solved
using the multiple isomorphous replacement method at a resolution of
3.0 Å using four heavy atom derivatives: K2PtCl4, methyl mercury chloride,
p-chloromercuribenzenesulfonic acid, and mersalyl acid.
These data are presented in Table III. The structure was refined at 2.1 Å resolution to the R
value of 0.185 and Rfree of 0.254, respectively.
The root mean square deviations of bond distances and angles from their
ideal values were 0.017 Å and 3.24°, respectively. The ( , )
values for all the amino acid residues except Thr264 fell
in a normal region in the Ramachandran plot (data not shown). The
crystal having a Vm = 2.9 Å3/Da
contains two molecules related with local 2-fold symmetry in an
asymmetric unit. ArATPh has a dimer structure (Fig.
2). One dimer molecule has two active
sites, and each active site binds one PLP. In both subunits, the
N-terminal region of residues 2-11 form a short -helix, but region
12-26 is missing in the final structure model because no significant
electron density was observed in the 2Fo Fc and Fo Fc maps for the region (Fig. 3). The molecule consists of two domains.
The large domain has a / structure comprised of six -helices
(H3-H8) and seven -strands (S1-S7), as assigned by the program
DSSP (49). The strands form a twisted sheet structure, on both sides of
which helices are arranged. The small domain consists of three
-helices (H10-H12) and a -strand (S8). A long -helix (H10)
links to the large domain via an -helix (H9).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 2.
The crystal structure of
ArATPh. C tracing of
ArATPh dimer. Subunits A and B are colored red
and blue, respectively. The PLP molecules are represented by
a ball-and-stick model. The figure was produced using the program
Turbo-Frodo.
|
|

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 3.
The folding topology of the monomer of
ArATPh. A, -helices, -strands,
and loops are colored red, blue, and
yellow, respectively. The green -helix
corresponds to the N-terminal -helix followed by the disordered
region. The -helices and -strands of the / structure are
numbered from the N terminus. The PLP molecules are represented by a
space-filling model. The figure produced using the program Turbo-Frodo.
B, topology diagram of ArATPh. -Helices are shown as
cylinders (red), -strands are arrows
(green), and the numbering is the same as that in
A. The sequential numbers of the first and last residues in
each secondary structure element are indicated.
|
|
The molecular replacement method using the structures
AspATEc, ArATPd, and cAspATp as templates
(6, 7, 50) was not successful for solving the ArATPh
structure because of poor identity of the primary sequences and a large
deviation in the main chain coordinates. By the least square fit after
superposing ArATPh on ArATPd, only 295 pairs of
corresponding amino acid residues were present in the C -C
distance less than 3 Å, and their root mean square deviation was 2.0 Å. Several structural differences were observed between
ArATPh and ArATPd as shown in Fig.
4. The 5th, 11th, and 13th -helices of
ArATPd are shorten by several amino acid residues in
ArATPh, corresponding to H4, H8, and H10, respectively.
Interestingly, the 9th -helix (from Tyr225 to
Val250) in the ArATPd molecule is transformed
into a long loop (from Tyr202 to Phe222)
between S5 and S6 of ArATPh. A loop
(Val345-Ser364) between H11 and S8 of the
small domain of ArATPh covers one end of the cleft formed at
the interface between the large and small domains, although the
corresponding loop is shorter in the ArATPd molecule and is
unable to form a lid on the cleft.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 4.
Superimposition of ArATPh
(green) on ArATPd
(red) (7). The figure was produced using
the program Turbo-Frodo. The PLP molecule of ArATPh is
represented by a space-filling model.
|
|
As shown in Figs. 5 and
6, PLP is positioned at the bottom of the
active site and forms an internal aldimine bond (Schiff base linkage)
with the catalytic residue Lys233 (corresponding to K258 in
cAspATp). The phosphate moiety of PLP forms hydrogen bonds with O of
Tyr59* (Tyr70* in cAspATp), N of
Ala96 (Thr109 in cAspATp), O of
Ser232 (Ala257 in cAspATp), and N 1 and N 2
of Arg241 (Arg266 in cAspATp; Fig.
5A). The pyridine ring of PLP interacts with both methyl
groups of Val201 (Ala224 in cAspATp) on one
side, and on the other side with the phenyl ring of Phe121
(Trp140 in cAspATp), by stacking interaction. The 0-3 atom
on the pyridine ring of PLP forms direct hydrogen bonds with the side
chains of Asn171 (Asn194 in cAspATp) and
Tyr202 (Tyr225 in cAspATp). The N1 atom on the
pyridine ring forms a hydrogen bond with the side chain of
Asp199 (Asp222 in cAspATp). Thus, PLP is fixed
tightly at the bottom of the active center.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
The PLP binding structure of
ArATPh. A, the stereoview for the
superposition of ArATPh (red) and
AspATEc (blue) by the PLP fitting. Although the
overall structure of AspATEc including the PLP binding
profile (6) is quite similar to that of ArATPd (7), the
AspATEc was selected as a reference structure for the
superposition because of its general popularity historically. The
residue numbers indicate the positions in the
ArATPh molecule (red). Dotted lines
indicate the hydrogen bonds in ArATPh (red).
B, nomenclature of atoms for PLP.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
The substrate-binding model for
ArATPh represented by stereoview. The front view
of the active site with Tyr. The model structure is presented in a
sphere with a 15-Å radius surrounding the substrate. The subunits A
and B are colored green and pink, respectively.
The substrates and PLP are colored blue and red,
respectively. The possible hydrogen bonds are represented as
dashed lines. The yellow figure, 3.4, indicates
the distance (Å) between the internal aldimine bond and the -amino
group of Tyr.
|
|
Gross Conformation and pH Stability--
The gross conformation
and pH stability of ArATPh were studied using CD
spectroscopy at 25 °C. The CD spectrum in the region between 200 and
250 nm exhibited double negative minima at 209 and 223, which are
characteristic of an -helical structure (data not shown). The
-helical content is estimated to be approximately 40%, according to
the method of Chen et al. (51). The enzyme is stable between
pH 4 and 11 for 24 h at 25 °C.
Heat Stability--
The residual ArATPh activity
remaining after heating was measured to determine the half-life of the
enzyme at 95 and 110 °C. The half-life of ArATPh is 30 min at 110 °C, and the enzyme is stable at 95 °C in 20 mM phosphate buffer (pH 6.5).
The heat capacity change of ArATPh was measured using
differential scanning calorimetry from 0 to 125 °C at pH 6.5. The
heat capacity change was only observed during the first scan in the differential scanning calorimetry measurement, indicating that the heat
denaturation profile of ArATPh is due to an irreversible denaturation process. The profile showed one major peak at 120.1 °C.
The molar enthalpy change, H, was calculated to be
2.4 × 103 kJ/mol for the homodimer.
 |
DISCUSSION |
Structural Elements Providing Hyperthermostability on
ArATPh--
ArATPh is one of the most thermostable
aminotransferases ever to be purified (52), having a melting
temperature of 120 °C. ArATPh is a homodimer in which
each subunit is constituted of two domains, similar to other well
characterized aminotransferases, such as AspATEc,
ArATPd, and cAspATp (6, 7, 50). However, its structure could
not be solved by the molecular replacement method because of a poor
sequence similarity, large deviation in the main chain coordinates, and
local changes in the secondary structure, including three shortened
-helices and a long loop transformed from an -helix (Fig. 4).
Another unique characteristic is its elongated loop between H11 and S8
(Figs. 3 and 4). The loop intimately connects two domains and covers
one end of the cleft formed at the interface of the two domains.
Because numerous hydrophobic residues were observed inside the cleft,
the elongated loop, which closely binds the two domains and acts like a
lid to shield the cleft from solvents, might be one of the factors that
account for the hyperthermostability of ArATPh.
On the basis of the ArATPh structures, the surface area for
one amino acid residue was calculated by dividing the accessible surface area of the dimer by total residue numbers to evaluate molecular compactness. The values of ArATPh and
ArATPd are 28.0 and 33.6 Å3, respectively. The
lower surface area for one residue of ArATPh molecule might
be due to tight packing of the polypeptide chain into the homodimer
structure. Another prominent difference in ArATPh is the
large number of charged residues (Asp, Glu, Lys, and Arg) on its
molecular surface compared with the ArATPd. The occupancy of
the charged residues in the accessible surface area of
ArATPh and ArATPd molecules are 73.3 and 48.1%,
respectively. On the contrary, the frequency of polar contacts less
than 3.3 Å, including hydrogen bond and ion pair among these charged
residues on the surface is decreased to 36.0% for ArATPh in
comparison with the value, 51.3%, of ArATPd. The accessible
surface of ArATPh has higher hydrophilicity with a lower
number of ion pairs than that of ArATPd. The compact packing
and the remarkably water-attractive surface of ArATPh are
probably major factors contributing to its hyperthermostability.
The PLP molecule of ArATPh is fixed tightly with nine
hydrogen bonds at the bottom of the active site cleft (Fig.
5A). One side of the pyridine ring of PLP interacts with the
geminal dimethyl groups of Val201 (Ala224 in
cAspATp), whereas the other side is stacked parallel with the phenyl
ring of Phe121 (Trp140 in cAspATp). In
AspATEc, the methyl group of Ala224 interacts
with the pyridine ring of PLP on one side, and on the other side, the
pyridine ring stacks to Trp140 with a 20° inclination
angle. In the thermophilic enzymes of subfamily I , valine or
isoleucine is found at the position corresponding to Val201
of ArATPh, whereas the residue is replaced with Ala in the
mesophilic enzymes of subfamily I (2, 3). The interaction of Ala
with PLP should be weaker than those of V/I in thermophilic
aminotransferases because of the lack of a geminal dimethyl-CH/
interaction (53). In subfamily I of the thermophilic archaea (Fig.
1), the phenyl ring of Phe or Tyr, corresponding to Phe121
in ArATPh, always stacks to the pyridine ring of PLP. In
subfamily I from the mesophilic organisms and subfamily I from
the thermophilic prokaryotes, these residues are replaced by
tryptophan, which has a bulkier side chain with a wider surface area
than does the phenyl ring (2). Consequently, a combination of the
Phe121 and Val201 residues stacking tightly to
the pyridine ring of PLP may contribute to the hyperthermophilic
properties of ArATPh. Further crystallographic studies are
in progress to better understand the mechanisms underlying the
hyperthermostability of this enzyme.
PLP-binding Structure of ArATPh--
In the PLP molecule of
ArATPh, the number of hydrogen bonds fixing the phosphate
moiety is reduced from six to five (Fig. 5A), because of
replacement of the Ser255 residue, which is conserved in
both AspATEc and ArATPd (6, 7). The large
conformational change of the phosphate moiety of PLP is induced by a
shift in the side chains of Ala96, Ser232, and
Arg241 from the corresponding residues in
AspATEc. The phosphate moiety moves parallel to the plane of
the pyridine ring of PLP, whereas the pyridine ring is conserved at the
same position as in AspATEc. The movement of the phosphate
moiety in the opposite direction might be a positive adjustment of the
cofactor to compensate for changes in the secondary structure that
account for its hyperthermostability. Interestingly, the O position
of Tyr202 in ArATPh is almost identical to that
of the corresponding Tyr225 residue of AspATEc
(Fig. 5A), whereas the coordinates of the main chain parts
in both Tyr residues are shifted by more than 2 Å. The Tyr residues of
both ArATPh and AspATEc are close enough to form
a hydrogen bond with O3H of PLP. The position of the
-carboxyl of Asp199 forming a hydrogen bond with N1H of
PLP is also identical to that of Asp222 of
AspATEc. These results strongly indicate that the pyridine ring must be fixed precisely at the conserved position in the active
center of ArATs to make the cofactor fully active, although the
phosphate moiety can be positioned according to the steric requirements. The O of the Tyr202 residue of
ArATPh can also form a hydrogen bond with the imino group of
the Schiff base. The angle of the imino proton on the C=N plane of
ArATPh is sufficient to form a hydrogen bond with Tyr202; however, the corresponding angle in
AspATEc seems less suitable to form a hydrogen bond with
Tyr225 (Fig. 5A). The pKa of
the Schiff base of ArATPh was determined to be 5.1, which is
the lowest value ever reported; the pKa values of
AspATEc, T. thermophilus AspAT, and ArATEc were reported to be 6.8 (54), 6.1 (8), and 6.65 (55), respectively. This low pKa value is probably due to
rotation of the C=N plane of the Schiff base against the pyridine ring of PLP to control hydrogen bonding between the imino group and the
Tyr202 residue and may also be due to the unique
environment around the PLP molecule caused by changes in the residues
stacked to PLP (Fig. 5A).
Active Site Structure and Substrate Binding Models--
The active
site structure with the best substrate, Tyr, is shown in Fig. 6. The
-carboxylate of Tyr was fixed at the active site by two salt bridges
with Arg362 (corresponding to R386 in cAspATp) and three
hydrogen bonds with Gly34, Asn171, and
Tyr320. The phenyl ring of Tyr and the aromatic group of
Phe121 undergo an energetically favorable
"edge-to-face" interaction (56), and the aromatic ring of
Tyr59* is located very closely, but not in parallel, to the
phenyl ring of Tyr. Thus, the best substrate can be trapped in the
hydrophobic pocket formed by Phe121, Tyr59*,
the pyridine ring of PLP, Met260* (corresponding to
Arg292* in cAspATp), and Val122
(Glu141 in cAspATp). In this binding model, the OH group of
Tyr is located at a distance sufficient to form hydrogen bonds with
O 1 of Thr264* (Ser296* in cAspATp) and with
the phosphate moiety of PLP. The internal aldimine bond between PLP and
Lys233 (corresponding to Lys258 in cAspATp) is
located so close that a new external aldimine bond can be formed
between PLP and the -amino group of Tyr.
Another binding model was formed with Glu, one of the best acidic
substrates. A water molecule (Xaa126*) is present at the
center of three adjacent groups: the -carboxyl of Glu, the O 1H of
Thr264*, and the phosphate residue of PLP. The proximity
(within 3 Å) of the water molecule and the adjacent residues allows
formation of a hydrogen-bond network among them. The water molecule
(Xaa126*) may be important in binding Glu to the active
center, as indicated by the reportedly complex structure of
ArATPd with maleate (7). Furthermore, the -carboxyl group
of Glu is parallel to the phenyl ring of Tyr59*, suggesting
a van der Waals' interaction between the two groups. This sort of weak
interaction may be important for the recognition of C5 substrates (Glu
and 2OG) in amino acid aminotransferases, because the Y70*S mutant of
AspATEc is reportedly less active against these substrates
(57). The phenyl ring at position 70 is essential for the recognition
of the Glu-2OG pair as substrates. Hence, in the binding model of
ArATPh, both ends of the acidic substrate, Glu, are fixed at
the active center of the enzyme by three major interactions: 1) salt
bridges between Arg362 and the -carboxylate of Glu, 2)
two hydrogen bonds located between Gly34 and the
-carboxylate, and between Gly34 and -amino groups of
the substrate, and 3) the capturing of the -carboxylate by the
hydrogen bond network through the water molecule Xaa126*
and by a weak interaction with Tyr59*. The low activity
against Asp is explained in two ways: 1) the lack of an arginine
residue corresponding to Arg292* of cAspATp, which
interacts with the distal carboxylate of the acidic substrate and 2)
the lack of a hydrogen bond network through the water molecule
Xaa126* and no interaction with Tyr59*, because
of a lack of one methylene unit at the position.
Substrate Specificity of ArATPh--
As shown in Tables I and II,
ArATPh prefers the substrates in the following order in
kmax/Kd: Tyr > Phe > Glu > Trp > His Met > Leu > Asp > Asn. The substrate specificity differs from those of the mesophilic
ArATs, including ArATPd, with the preference in
kcat/Km being Tyr > Phe = Asp > Trp > Glu (41). Thermostable ArATs from
Pyrococcus furiosus and Methanococcus aeolicus
were also reported to have distinct substrate specificity in
kcat/Km: Phe > Trp > Tyr (52, 58). Consequently, ArATPh has a novel substrate
specificity compared with other ArATs.
Aminotransferases are increasingly applied to the large scale synthesis
of unnatural and nonproteinogenic amino acids (1). Typically exhibiting
relaxed substrate specificity, rapid reaction rates, and no need for
cofactor regeneration, they possess many characteristics that make them
useful for biocatalysis. Because of its novel substrate specificity and
high level of resistance to organic solvents (data not shown),
ArATPh will continue to be a useful biocatalysis for the
synthesis of unnatural compounds.
 |
ACKNOWLEDGEMENTS |
We thank Miyuki Ishimura for assistance with
the differential scanning calorimetry analysis and valuable
discussions. Koichi Honda is gratefully acknowledged for his practical
advice and valuable discussions.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1DJU) have
been deposited in the Protein Data Bank, Brookhaven National Laboratory, Upton, NY.
§
To whom correspondence should be addressed. For I. M., Tel.:
81-298-546142; Fax: 81-298-546151 and for K. H., Tel.: 81-298-546194; Fax: 81-298-546194.
2
Asterisks after the residue number indicate the
residues supplied by the other subunit of the dimer.
 |
ABBREVIATIONS |
The abbreviations used are:
AspAT, aspartate
aminotransferase;
AT, aminotransferase;
ArATPh, aromatic
amino acid AT from P. horikoshii;
cAspATp, pig cytosolic
AspAT;
AspATEc, E. coli AspAT;
ArATEc, E. coli ArAT;
ArATPd, P. denitrificans
ArAT;
PLP, pyridoxal 5'-phosphate;
KetoPhe, phenylpyruvate;
2OG, 2-oxoglutaric acid;
DTNB, 5,5'-dithiobis (2-nitrobenzoic acid);
MES, 2-(N-morpholino)ethanesulfonic acid;
PIPES, 1,4-piperazinediethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Taylor, P. P.,
Pantaleone, D. P.,
Senkpeil, R. F.,
and Fotheringham, I. G.
(1998)
Trends Biotechnol.
16,
412-418[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Mehta, P. K.,
Hale, T. I.,
and Christen, P.
(1993)
Eur. J. Biochem.
214,
549-561[Medline]
[Order article via Infotrieve]
|
| 3.
|
Jensen, R. A.,
and Gu, U.
(1996)
J. Bacteriol.
178,
2161-2171[Free Full Text]
|
| 4.
|
Ovchinnikov, Yu. A.,
Egorov, C. A.,
Aldanova, N. A.,
Feigina, M. Yu.,
Lipkin, V. M.,
Abdulaev, N. G.,
Grishin, E. V.,
Kiselev, A. P.,
Modyanov, N. N.,
Braunstein, A. E.,
Polyanovsky, O. L.,
and Nosikov, V. V.
(1973)
FEBS Lett.
29,
31-34[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Kirsch, J. F.,
Eichele, G.,
Ford, G. C.,
Vincent, M. G.,
Janonius, J. N.,
Gehring, H.,
and Christen, P.
(1984)
J. Mol. Biol.
174,
497-525[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Okamoto, A.,
Higuchi, T.,
Hirotsu, K.,
Kuramitsu, S.,
and Kagamiyama, H.
(1994)
J. Biochem. (Tokyo)
116,
95-107[Abstract/Free Full Text]
|
| 7.
|
Okamoto, A.,
Nakai, Y.,
Hayashi, H.,
Hirotsu, K.,
and Kagamiyama, H.
(1998)
J. Mol. Biol.
280,
443-561[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Okamoto, A.,
Kato, R.,
Masui, R.,
Yamagishi, A.,
Oshima, T.,
and Kuramitsu, S.
(1996)
J. Biochem. (Tokyo)
119,
135-144[Abstract/Free Full Text]
|
| 9.
|
Birolo, L.,
Arnone, M. I.,
Cubellis, M. V.,
Andreotti, G.,
Nitti, G.,
Marino, G.,
and Sannia, G.
(1991)
Biochim. Biophys. Acta
1080,
198-204[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Cowan, D. A.,
Daniel, R. M.,
and Morgan, H. W.
(1985)
Trends Biotechnol.
3,
68-72[CrossRef]
|
| 11.
|
Cowan, D. A.
(1992)
Trends Biotechnol.
10,
315-332[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Crooker, P. M.,
Sako, Y.,
and Uchida, M.
(1999)
Extremophiles
3,
3-9[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Adams, M. W.,
Perler, F. B.,
and Kelly, R. M.
(1999)
Bio/Technology
13,
662-668
|
| 14.
|
Kawarabayasi, Y.,
Sawada, M.,
Horikoshi, H.,
Haikawa, Y.,
Hino, Y.,
Yamamoto, S.,
Sekine, M.,
Baba, S.,
Kosugi, H.,
Hosoyama, A.,
Nagai, Y.,
Sakai, M.,
Ogura, K.,
Otsuka, R.,
Nakazawa, H.,
Takamiya, M.,
Ohfuku, Y.,
Funahashi, T.,
Tanaka, T.,
Kudoh, Y.,
Yamazaki, J.,
Kushida, N.,
Oguchi, A.,
Aoki, K.,
Yoshizawa, T.,
Nakamura, Y.,
Robb, F. T.,
Horikoshi, K.,
Masuchi, Y.,
Shizuya, H.,
and Kikuchi, H.
(1998)
DNA Res.
5,
55-76[Abstract]
|
| 15.
|
Kawarabayasi, Y.,
Sawada, M.,
Horikoshi, H.,
Haikawa, Y.,
Hino, Y.,
Yamamoto, S.,
Sekine, M.,
Baba, S.,
Kosugi, H.,
Hosoyama, A.,
Nagai, Y.,
Sakai, M.,
Ogura, K.,
Otsuka, R.,
Nakazawa, H.,
Takamiya, M.,
Ohfuku, Y.,
Funahashi, T.,
Tanaka, T.,
Kudoh, Y.,
Yamazaki, J.,
Kushida, N.,
Oguchi, A.,
Aoki, K.,
Yoshizawa, T.,
Nakamura, Y.,
Robb, F. T.,
Horikoshi, K.,
Masuchi, Y.,
Shizuya, H.,
and Kikuchi, H.
(1998)
DNA Res.
5,
147-155[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Ishikawa, K.,
Ishida, H.,
Koyama, Y.,
Kawarabayasi, Y.,
Kawahara, J.,
Matsui, E.,
and Matsui, I.
(1998)
J. Biol. Chem.
273,
17726-17731[Abstract/Free Full Text]
|
| 17.
|
Laemmli, U. K.
(1970)
Nature
227,
680-682[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Kawaguchi, S.,
Nobe, Y.,
Yasuoka, J.,
Wakamiya, T.,
Kusumoto, S.,
and Kuramitsu, S.
(1997)
J. Biochem. (Tokyo)
122,
55-63[Abstract/Free Full Text]
|
| 19.
|
Kuramitsu, S.,
Hiromi, K.,
Hayashi, H.,
Morino, Y.,
and Kagamiyama, H.
(1990)
Biochemistry
29,
5469-5476[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Fersht, A.
(1985)
Enzyme Structure and Mechanism
, 2nd Ed.
, pp. 311-346, W. H. Freeman and Company, New York
|
| 21.
|
Karmen, A.,
Wroeblewski, F.,
and LaDue, J. S.
(1955)
J. Clin. Invest.
34,
126-133
|
| 22.
|
Inoue, K.,
Kuramitsu, S.,
Aki, K.,
Watanabe, Y.,
Takagi, T.,
Nishigai, M.,
Ikai, A.,
and Kagamiyama, H.
(1988)
J. Biochem. (Tokyo)
104,
777-784[Abstract/Free Full Text]
|
| 23.
|
Spolter, P. D.,
and Baldridge, R. C.
(1963)
J. Biol. Chem.
238,
2071-2074[Free Full Text]
|
| 24.
|
Marino, G.,
Nitti, G.,
Arnone, M. I.,
Sannia, G.,
Gambacorta, A.,
and De Rosa, M.
(1988)
J. Biol. Chem.
263,
12305-12309[Abstract/Free Full Text]
|
| 25.
|
Brunger, A. T.
(1992)
X-PLOR, version 3.1
, pp. 1-269, Yale University Press, New Haven
|
| 26.
|
Sung, M. H.,
Tanizawa, K.,
Tanaka, H.,
Kuramitsu, S.,
Kagamiyama, H.,
Hirotsu, K.,
Okamoto, A.,
Higuchi, T.,
and Soda, K.
(1991)
J. Biol. Chem.
266,
2567-2572[Abstract/Free Full Text]
|
| 27.
|
Watson, R. J.,
and Rastogi, V. K.
(1993)
J. Bacteriol.
175,
1919-1928[Abstract/Free Full Text]
|
| 28.
|
Trach, K. A.,
and Hoch, J. A.
(1993)
Mol. Microbiol.
8,
69-79[Medline]
[Order article via Infotrieve]
|
| 29.
|
Bult, C. J.,
White, O.,
Olsen, G. J.,
Zhou, L.,
Fleischmann, R. D.,
Sutton, G. G.,
Blake, J. A.,
FitzGerald, L. M.,
Clayton, R. A.,
Gocayne, J. D.,
Kerlavage, A. R.,
Dougherty, B. A.,
Tomb, J. F.,
Adams, M. D.,
Reich, C. I.,
Overbeek, R.,
Kirkness, E. F.,
Weinstock, K. G.,
Merrick, J. M.,
Glodek, A.,
Scott, J. L.,
Geoghagen, N. S. M.,
and Venter, J. C.
(1996)
Science
273,
1058-1073[Abstract]
|
| 30.
|
Cubellis, M. V.,
Rozzo, C.,
Nitti, G.,
Arnone, M. I.,
Marino, G.,
and Sannia, G.
(1989)
Eur. J. Biochem.
186,
375-381[Medline]
[Order article via Infotrieve]
|
| 31.
|
Rettenmeier, R.,
Natt, E.,
Zentgraf, H.,
and Scherer, G.
(1990)
Nucleic Acids Res.
18,
3853-3861[Abstract/Free Full Text]
|
| 32.
|
Grange, T.,
Guenet, C.,
Dietrich, J. B.,
Chasserot, S.,
Fromont, M.,
Befort, N.,
Jami, J.,
Beck, G.,
and Pictet, R.
(1985)
J. Mol. Biol.
184,
347-350[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Bontempi, E. J.,
Bau, J.,
Aslund, L.,
Porcel, B.,
Segura, E. L.,
Henriksson, J.,
Orn, A.,
Pettersson, U.,
and Ruiz, A. M.
(1993)
Mol. Biochem. Parasitol.
59,
253-262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Ishiguro, M.,
Takio, K.,
Suzuki, M.,
Oyama, R.,
Matsuzawa, T.,
and Titani, K.
(1991)
Biochemistry
30,
10451-10457[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Ishiguro, M.,
Suzuki, M.,
Takio, K.,
Matsuzawa, T.,
and Titani, K.
(1991)
Biochemistry
30,
6048-6053[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Son, D.,
and Sugiyama, T.
(1992)
Plant Mol. Biol.
20,
705-713[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Nei, M.
(1987)
Molecular Evolutionary Genetics
, pp. 293-298, Columbia University Press, New York
|
| 38.
|
Kuramitsu, S.,
Okuno, S.,
Ogawa, T.,
Ogawa, H.,
and Kagamiyama, H.
(1985)
J. Biochem. (Tokyo)
97,
1259-1262[Abstract/Free Full Text]
|
| 39.
|
Hayashi, H.,
Inoue, K.,
Nagata, T.,
Kuramitsu, S.,
and Kagamiyama, H.
(1993)
Biochemistry
32,
12229-12239[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kuramitsu, S.,
Inoue, K.,
Ogawa, T.,
Ogawa, H.,
and Kagamiyama, H.
(1985)
Biochem. Biophys. Res. Commun.
133,
134-139[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Oue, S.,
Okamoto, A.,
Nakai, Y.,
Nakahira, M.,
Shibatani, T.,
Hayashi, H.,
and Kagamiyama, H.
(1997)
J. Biochem. (Tokyo)
121,
161-171[Abstract/Free Full Text]
|
| 42.
|
Sung, M.,
Tanizawa, K.,
Tanaka, H.,
Kuramitsu, S.,
Kagamiyama, H.,
and Soda, K.
(1990)
J. Bacteriol.
172,
1345-1351[Abstract/Free Full Text]
|
| 43.
|
Andersson, S. M.,
and Pispa, J. P.
(1982)
Clin. Chim. Acta
125,
117-123[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Hargrove, J. L.,
Scoble, H. A.,
Mathews, W. R.,
Braumstark, B. R.,
and Biemann, K.
(1989)
J. Biol. Chem.
264,
45-53[Abstract/Free Full Text]
|
| 45.
|
Montemartini, M.,
Santome, J. A.,
Cazzulo, J. J.,
and Nowicki, C.
(1993)
Biochem. J.
292,
901-906
|
| 46.
|
Adams, M. W. W.
(1992)
Adv. Inorg. Chem.
38,
341-396
|
| 47.
|
Park, J.-B.,
Fan, C.,
Hoffman, B. M.,
and Adams, M. W. W.
(1991)
J. Biol. Chem.
266,
19351-19356[Abstract/Free Full Text]
|
| 48.
|
Klump, H.,
Di Ruggiero, J.,
Kessel, M.,
Park, J.-B.,
Adams, M. W. W.,
and Robb, F. T.
(1992)
J. Biol. Chem.
267,
22681-22685[Abstract/Free Full Text]
|
| 49.
|
Kabsch, W.,
and Sander, C.
(1983)
Biopolymers
22,
2577-2637[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Rhee, S.,
Silva, M. M.,
Hyde, C. C.,
Rogers, P. H.,
Metzler, C. M.,
Metzler, D. E.,
and Arnone, A.
(1997)
J. Biol. Chem.
272,
17293-17302[Abstract/Free Full Text]
|
| 51.
|
Chen, Y. H.,
Yang, J. T.,
and Martinez, H. M.
(1972)
Biochemistry
11,
4120-4131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Andreotti, G.,
Cubellis, M. V.,
Nitti, G.,
Sannia, G.,
Mai, X.,
Adams, M. W. W.,
and Marino, G.
(1995)
Biochim. Biophys. Acta
1247,
90-96[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Nishio, M.,
Umezawa, Y.,
Hiroto, M.,
and Takeuchi, Y.
(1995)
Tetrahedron
51,
8665-8701[CrossRef]
|
| 54.
|
Miyazawa, K.,
Kawaguchi, S.,
Okamoto, A.,
Kato, R.,
Ogawa, T.,
and Kuramitsu, S.
(1994)
J. Biochem. (Tokyo)
115,
568-577[Abstract/Free Full Text]
|
| 55.
|
Iwasaki, M.,
Hayashi, H.,
and Kagamiyama, H.
(1994)
J. Biochem. (Tokyo)
115,
156-161[Abstract/Free Full Text]
|
| 56.
|
Burley, S. K.,
and Petsko, G. A.
(1986)
J. Am. Chem. Soc.
108,
7995-8001[CrossRef]
|
| 57.
|
Inoue, K.,
Kuramitsu, S.,
Okamoto, A.,
Hirotsu, K.,
Higuchi, T.,
and Kagamiyama, H.
(1991)
Biochemistry
30,
7796-7801[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Xing, R.,
and Whiteman, W. B.
(1992)
J. Bacteriol.
174,
541-548[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. J. Fernandez, M. C. Vega, F. Lehmann, E. Sandmeier, H. Gehring, P. Christen, and M. Wilmanns
Structural Studies of the Catalytic Reaction Pathway of a Hyperthermophilic Histidinol-phosphate Aminotransferase
J. Biol. Chem.,
May 14, 2004;
279(20):
21478 - 21488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Goto, R. Omi, I. Miyahara, A. Hosono, H. Mizuguchi, H. Hayashi, H. Kagamiyama, and K. Hirotsu
Crystal Structures of Glutamine:Phenylpyruvate Aminotransferase from Thermus thermophilus HB8: INDUCED FIT AND SUBSTRATE RECOGNITION
J. Biol. Chem.,
April 16, 2004;
279(16):
16518 - 16525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Song, H. Lu, and J. T. Greenberg
Divergent Roles in Arabidopsis thaliana Development and Defense of Two Homologous Genes, ABERRANT GROWTH AND DEATH2 and AGD2-LIKE DEFENSE RESPONSE PROTEIN1, Encoding Novel Aminotransferases
PLANT CELL,
February 1, 2004;
16(2):
353 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hosono, H. Mizuguchi, H. Hayashi, M. Goto, I. Miyahara, K. Hirotsu, and H. Kagamiyama
Glutamine:phenylpyruvate Aminotransferase from an Extremely Thermophilic Bacterium, Thermus thermophilus HB8
J. Biochem.,
December 1, 2003;
134(6):
843 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Kuettner, R. Hilgenfeld, and M. S. Weiss
The Active Principle of Garlic at Atomic Resolution
J. Biol. Chem.,
November 22, 2002;
277(48):
46402 - 46407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, J. B. Anderson, J. Chen, L. Y. Geer, S. He, D. I. Hurwitz, C. A. Liebert, T. Madej, G. H. Marchler, A. Marchler-Bauer, et al.
MMDB: Entrez's 3D-structure database
Nucleic Acids Res.,
January 1, 2002;
30(1):
249 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|